Gunaratne S, Taylor B, Zucker J, Wilkin T, Tieu H
Top Antivir Med. 2025; 32(4):542-567.
PMID: 39746674
PMC: 11361756.
Ay S, Burlaud-Gaillard J, Gazi A, Tatirovsky Y, Cuche C, Diana J
EMBO J. 2024; 44(1):166-199.
PMID: 39623137
PMC: 11697293.
DOI: 10.1038/s44318-024-00316-w.
Saez-Cirion A, Mamez A, Avettand-Fenoel V, Nabergoj M, Passaes C, Thoueille P
Nat Med. 2024; 30(12):3544-3554.
PMID: 39222660
PMC: 11645271.
DOI: 10.1038/s41591-024-03277-z.
Mainou E, Berendam S, Obregon-Perko V, Uffman E, Phan C, Shaw G
Epidemics. 2024; 48:100780.
PMID: 38964130
PMC: 11518701.
DOI: 10.1016/j.epidem.2024.100780.
Mainou E, Berendam S, Obregon-Perko V, Uffman E, Phan C, Shaw G
bioRxiv. 2024; .
PMID: 38895223
PMC: 11185557.
DOI: 10.1101/2024.06.01.596971.
Pembrolizumab in an HIV-infected patient with glioblastoma.
Yuen C, Bao S, Pekmezci M, Mo F, Kong X
Immunotherapy. 2024; 16(12):803-811.
PMID: 38889068
PMC: 11457652.
DOI: 10.1080/1750743X.2024.2362566.
Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission.
Bengu N, Cromhout G, Adland E, Govender K, Herbert N, Lim N
Nat Med. 2024; 30(10):2796-2804.
PMID: 38843818
PMC: 11485204.
DOI: 10.1038/s41591-024-03105-4.
High Prevalence of Unconfirmed Positive HIV Polymerase Chain Reaction Test Results Among African Infants With HIV Exposure in the International Epidemiology Databases to Evaluate AIDS Consortium.
Carlucci J, Huntington T, Technau K, Yotebieng M, Leroy V, Anderson K
Clin Infect Dis. 2024; 79(6):1475-1478.
PMID: 38742844
PMC: 11650864.
DOI: 10.1093/cid/ciae251.
More than the Infinite Monkey Theorem: NHP Models in the Development of a Pediatric HIV Cure.
Fonseca J, King A, Chahroudi A
Curr HIV/AIDS Rep. 2024; 21(1):11-29.
PMID: 38227162
PMC: 10859349.
DOI: 10.1007/s11904-023-00686-6.
Age at ART initiation and proviral reservoir size in perinatal HIV-1 infection: considerations for ART-free remission.
Bekka S, Kelly K, Haaren M, Dhummakupt A, Persaud D
Curr Opin HIV AIDS. 2024; 19(2):79-86.
PMID: 38169427
PMC: 11715321.
DOI: 10.1097/COH.0000000000000839.
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials.
Reeves D, Mayer B, deCamp A, Huang Y, Zhang B, Carpp L
Nat Commun. 2023; 14(1):8299.
PMID: 38097552
PMC: 10721814.
DOI: 10.1038/s41467-023-43384-y.
HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept study.
Persaud D, Bryson Y, Nelson B, Tierney C, Cotton M, Coletti A
Lancet HIV. 2023; 11(1):e20-e30.
PMID: 38061376
PMC: 11094801.
DOI: 10.1016/S2352-3018(23)00236-9.
New Concepts in Therapeutic Manipulation of HIV-1 Transcription and Latency: Latency Reversal versus Latency Prevention.
Lewis C, Margolis D, Browne E
Viruses. 2023; 15(8).
PMID: 37632019
PMC: 10459382.
DOI: 10.3390/v15081677.
Effective early antiretroviral therapy in perinatal-HIV infection reduces subsequent plasma inflammatory profile.
Nguyen A, Plotkin A, Odumade O, de Armas L, Pahwa S, Morrocchi E
Pediatr Res. 2023; 94(5):1667-1674.
PMID: 37308683
DOI: 10.1038/s41390-023-02669-0.
Controversies in the Design of Strategies for the Cure of HIV Infection.
de Gea-Grela A, Moreno S
Pathogens. 2023; 12(2).
PMID: 36839593
PMC: 9961067.
DOI: 10.3390/pathogens12020322.
Advances in Pediatric HIV-1 Cure Therapies and Reservoir Assays.
Khetan P, Liu Y, Dhummakupt A, Persaud D
Viruses. 2022; 14(12).
PMID: 36560612
PMC: 9787749.
DOI: 10.3390/v14122608.
Sustained Virologic Suppression Reduces HIV-1 DNA Proviral Levels and HIV Antibodies in Perinatally HIV-Infected Children Followed from Birth.
Fuller T, Kerin T, Cortado R, Benamor Teixeira M, Fragoso da Silveira Gouvea M, Moreira C
Viruses. 2022; 14(11).
PMID: 36366448
PMC: 9693172.
DOI: 10.3390/v14112350.
Early treatment regimens achieve sustained virologic remission in infant macaques infected with SIV at birth.
Wang X, Vincent E, Siddiqui S, Turnbull K, Lu H, Blair R
Nat Commun. 2022; 13(1):4823.
PMID: 35973985
PMC: 9381774.
DOI: 10.1038/s41467-022-32554-z.
Healthy dynamics of CD4 T cells may drive HIV resurgence in perinatally-infected infants on antiretroviral therapy.
Morris S, Strehlau R, Shiau S, Abrams E, Tiemessen C, Kuhn L
PLoS Pathog. 2022; 18(8):e1010751.
PMID: 35969641
PMC: 9410541.
DOI: 10.1371/journal.ppat.1010751.
Immune correlates of HIV-1 reservoir cell decline in early-treated infants.
Hartana C, Garcia-Broncano P, Rassadkina Y, Lian X, Jiang C, Einkauf K
Cell Rep. 2022; 40(3):111126.
PMID: 35858580
PMC: 9314543.
DOI: 10.1016/j.celrep.2022.111126.
